AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,777,000 | -26.8% | 155,838 | +2.8% | 0.04% | -23.2% |
| Q2 2021 | $2,428,000 | -10.4% | 151,638 | 0.0% | 0.06% | -13.8% |
| Q1 2021 | $2,710,000 | +67.7% | 151,638 | +26.7% | 0.06% | +62.5% |
| Q4 2020 | $1,616,000 | +12.5% | 119,638 | -2.0% | 0.04% | +2.6% |
| Q3 2020 | $1,436,000 | +96.4% | 122,038 | +146.4% | 0.04% | +105.3% |
| Q2 2020 | $731,000 | +8.0% | 49,538 | -1.2% | 0.02% | -5.0% |
| Q1 2020 | $677,000 | -45.4% | 50,138 | -2.3% | 0.02% | -23.1% |
| Q4 2019 | $1,240,000 | – | 51,308 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |